Tenocyte proliferation on collagen scaffolds protects against degradation and improves scaffold properties

Journal of Materials Science: Materials in Medicine

Volumn 23, Issue 3, 2012, Pages 823-833

  Tilley, J M R ^a   Chaudhury, S ^b   Hakimi, O ^b   Carr, A J ^b   Czernuszka, J T ^a  

^a UNIVERSITY OF OXFORD   (United Kingdom)

^b UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BIOCHEMICAL ASSAY; COLLAGEN CONTENT; COLLAGEN SCAFFOLDS; CULTURE MEDIUM; DENATURATION TEMPERATURES; EXTRACELLULAR MATRIX DEPOSITION; MATERIAL PROPERTY; SCAFFOLD DEGRADATION; SCAFFOLD PROPERTIES; SULFHYDRYL CONTENT; TENOCYTE; TISSUE ENGINEERING SCAFFOLD; TISSUE REGENERATION;

CELL PROLIFERATION; COLLAGEN; DEGRADATION; DIFFERENTIAL SCANNING CALORIMETRY; MECHANICAL PROPERTIES; MECHANICAL TESTING; TISSUE;

SCAFFOLDS (BIOLOGY);

COLLAGEN; MOLECULAR SCAFFOLD; THIOL DERIVATIVE; TISSUE SCAFFOLD;

ARTICLE; CELL PROLIFERATION; CELL STRUCTURE; CELL VIABILITY; CELLS; CULTURE MEDIUM; DEGRADATION; DENATURATION; DIFFERENTIAL SCANNING CALORIMETRY; HISTOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; INFRARED SPECTROSCOPY; MECHANICS; PRIORITY JOURNAL; SURFACE PROPERTY; TEMPERATURE; TENOCYTE; CHEMISTRY; CYTOLOGY; TENDON; TISSUE ENGINEERING;

CALORIMETRY, DIFFERENTIAL SCANNING; CELL PROLIFERATION; COLLAGEN; SPECTROSCOPY, FOURIER TRANSFORM INFRARED; TENDONS; TISSUE ENGINEERING;

EID: 84862735774     PISSN: 09574530     EISSN: 15734838     Source Type: Journal    
DOI: 10.1007/s10856-011-4537-7     Document Type: Article

References (38)

1. Cummins CA, Murrell GAC Mode of failure for rotator cuff repair with suture anchors identified at revision surgery. J Shou Id Elbow Surg. 2003;12(2):128-33.
2. Mura N, O'Driscoll SW, Zobitz ME, Heers G, An KN. Biome-chanical effect ofpatch graft for large rotator cufftears: a cadaver study. Clin Orthop Relat Res. 2003;415:131-8.
3. Gerber C, Fuchs B, Hodler J. The results of repair of massive tears of the rotator cuff. J Bone Joint Surg. 2000;82(4):505-15.
4. Sachlos E, Reis N, Ainsley C, Derby B, Czernuszka JT. Nove1 co Uagen scaffolds with predefined internal morphology made by solid freeform fabrication. Biomaterials. 2003;24(8): 1487-97.
5. Sengers BG, Taylor M, Please CP, Oreffo ROC. Computational modelling of cell spreading and tissue regeneration in porous scaffolds. Biomaterials. 2007;28(10):1926-40.
6. Göpferich A. Mechanisms of polymer degradation and erosion. Polym Scaffold Hard Tissue Eng. 1996;17(2):103-14.
7. Chao G, Xiaobo S, Chenglin C, Yinsheng D, Yuepu P, Pinghua L. A cellular automaton simulation of the degradation of porous polylactide scaffold: I Effect of porosity. Mater Sci Eng C. 2009;29(6):1950-8.
8. Agrawal CM, Mc Kinney JS, Lanctot D, Athanasiou KA. Effects of fluid flow on the in vitro degradation kinetics of biodegradable scaffolds for tissue engineering. Biomaterials. 2000;21(23): 2443-52.
9. Gong Y, Zhou Q, Gao C, Shen J. In vitro and in vivo degrada-bility and cytocompatibility of poly(l-lactic acid) Scaffold fabri-cated by a gelatin particle leaching method. Acta Biomater. 2007;3(4):531-40.
10. Leenslag JW, Pennings AJ, Bos RRM, Rozema FR, Boering G. Resorbable materia Is of poly(l-lactide): VII In vivo and in vitro degradation. Biomaterials. 1987;8(4):3ll-4.
11. Yahyouche A, Zhidao X, Czernuszka JT, Clover AJP. Macro-phage-mediated degradation of crosslinked co Uagen scaffolds. Acta Biomater. 2011;7(1):278-86.
12. Shea KP, Mc Carthy MB, Ledgard F, Arciero C, Chowaniec D, Mazzocca AD. Human tendon cell response to 7 commercially available extracellular matrix materials: an in vitro study arthroscopy. J Arthrosc Relat Surg. 2010;26(9):1181-8.
13. Stoll C, John T, Endres M, Rosen C, Kaps C, Kohl B et al. Extracellular matrix expression of human tenocytes in three-dimensional air-liquid and PLGA cultures compared with tendon tissue: Implications for tendon tissue engineering. J Orthop Res. 2010;28(9):1170-7. doi:10.1002/jor.21109.
14. Charulatha V, Rajaram A. Influence of different crosslinking treatments on the physical properties of co Uagen membranes. Biomaterials. 2003;24(5):759-67.
15. O'Liveira SM, Ringshia RA, Legeros RZ, Clark E, Yost MJ, Terracio L et al. An improved co Uagen Scaffold for skeletal regeneration. J Biomed Mater Res A. 2010 (Early View).
16. Haugh MG, Murphy CM, Mc Kiernan RC, Altenbuchner C, O'Brien FJ. Crosslinking and mechanical properties significantly influence cell attachment, proliferation, and migration within co Uagen glycosaminoglycan scaffolds. Tissue Eng A. 2010; 17(9-10):1201-8. doi:10.1089/ten.tea.2010.0590.
17. Cao D, Liu W, Wei X, Xu F, Cui L, Cao Y. In vitro tendon engineering with avian tenocytes and polyglycolic acids: a pre-liminary report. Tissue Eng. 2006;12(5):1369-77.
18. Ge Z, Yang F, Goh JCH, Ramakrishna S, Lee EH. Biomateria Is and scaffolds for ligament tissue engineering. J Biomed Mater Res A. 2006;77A(3):639-52.
19. Chen G, Liu D, Maruyama N, Ohgushi H, Tanaka J, Tateishi T. Cell adhesion of bone marrow cells, chondrocytes, ligament ce Us and synovial ce Us on a PLGA-co Uagen hybrid mesh. Mater Sci Eng C. 2004;24(6-8):867-73.
20. Powell HM, Boyce ST. EDC cross-linking improves skin sub-stitute strength and stability. Biomaterials 2006;27(34):5821-7.
21. Willows A, Fan Q, Ismail F, Vaz CM, Tomlins PE, Mikhalovska LI, et al. Assessment of tissue Scaffold degradation using elec-trochemical techniques. Acta Biomater. 2008;4(3):686-96.
22. Pek YS, Spector M, Yannas IV, Gibson LJ. Degradation of a collagen-chondroitin-6-sulfate matrix by collagenase and by chondroitinase. Biomaterials. 2004;25(3):473-82.
23. Olde Damink LHH, Dijkstra PJ, van Luyn MJA, van Wachem PB, Nieuwenhuis P, Feijen J. In vitro degradation of dermal sheep co Uagen cross-linked using a water-soluble carbodiimide. Biomaterials. 1996;17(7):679-84.
24. Wolfgang F. Co Uagen-biomaterial for drug delivery. Eur J Pharm Biopharm. 1998;45(2):113-36.
25. Kato YP, Dunn MG, Zawadsky JP, Tria AJ, Silver FH. Regen-eration of Achilles tendon with a co Uagen tendon prosthesis. Results of a one-year implantation study. J Bone Joint Surg. 1991;73(4):561-74.
26. Goldstein JD, Tria AJ, Zawadsky JP, Kato YP, Christiansen D, Silver FH. Development of a reconstituted co Uagen tendon prosthesis A preliminary implantation study. J Bone Joint Surg. 1989;71(8):1183-91.
27. Lamberti PM, Wezeman FH. Biologic behavior of an in vitro hydrated co Uagen gel-human tenocyte tendon model. Clin Ort-hop Relat Res. 2002;397:414-23.
28. Grinnell F, Lamke CR. Reorganization of hydrated co Uagen lattices by human skin fibroblasts. J Cell Sci. 1984;66(1):51-63.
29. Gigante A, Cesari E, Busilacchi A, Manzotti S, Kyriakidou K, Greco F et al. Co Uagen I membranes for tendon repair: Effect of co Uagen fiber orientation on cell behavior. J Orthop Res. 2009;27(6):826-32. doi:10.1002/jor.20812.
30. Byth H-A, Mchunu BI, Dubery IA, Bornman L. Assessment of a simple, non-toxic alamar blue cell survival assay to monitor tomato cell viability. Phytochem Anal. 2001;12(5):340-6.
31. Graham CE, Waitkoff HK, Hier SW. The amino acid content of some scleroproteins. J Biol Chem. 1949;177(2):529-32.
32. Moore SM, Mc Mahon PJ, Azemi E, Debski RE. Bi-directional mechanical properties of the posterior region of the glenohumeral capsule. J Biomech. 2005;38(6):1365-9.
33. Kato YP, Christiansen DL, Hahn RA, Shieh S-J, Goldstein JD, Silver FH. Mechanical properties of co Uagen fibres: a comparison of reconstituted and rat tail tendon fibres. Biomaterials. 1989;10(1):38-42.
34. Bigi A, Cojazzi G, Roveri N, Koch MHJ. Differential scanning calorimetry and X-ray diffraction study of tendon co Uagen ther-mal denaturation. Int J Biol Macromol. 1987;9(6):363-7.
35. Martini FH. Fundamenta Is of anatomy and physiology. 4th ed. Upper Saddle River, NJ: Prentice Hall, Inc.; 1998.
36. Vernon RB, Gooden MD. An improved method for the co Uagen gel contraction assay. In Vitro Cell Dev Biol Anim. 2002;38(2):97-101. doi:10.1290/1071- 2690(2002)0382.0.co;2.
37. Schulz Torres DM, Freyman T, Yannas IV, Spector M. Tendon cell contraction of co Uagen-GAG matrices in vitro: effect of cross-linking. Biomaterials. 2000;21(15):1607-19.
38. Gough KM, Zelinski D, Wiens R, Rak M, Dixon IMC. Fourier transform infrared evaluation of microscopic scarring in the cardiomyopathic heart: effect of chronic AT1 suppression. Anal Biochem. 2003;316(2):232-42.